Navigation Links
INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia
Date:12/12/2007

ge your heart rhythm. This effect is potentially serious, and you should talk to your doctor about any current or past heart problems. Some medications interact with INVEGA. Please inform your healthcare professional of any medications or supplements that you are taking.

Neuroleptic Malignant Syndrome (NMS) is a rare and potentially fatal side effect reported with INVEGA and similar medicines. Call your doctor immediately if the person being treated develops symptoms such as high fever; stiff muscles; shaking; confusion; sweating; changes in pulse, heart rate, or blood pressure; or muscle pain and weakness. Treatment should be stopped if the person being treated has NMS.

Tardive Dyskinesia (TD) is a serious, sometimes permanent side effect reported with INVEGA and similar medications. TD includes uncontrollable movements of the face, tongue, and other parts of the body. The risk of developing TD and the chance that it will become permanent is thought to increase with the length of therapy and the overall dose taken by the patient. This condition can develop after a brief period of therapy at low doses, although this is much less common. There is no known treatment for TD, but it may go away partially or completely if therapy is stopped.

INVEGA should be used cautiously in people with a seizure disorder, who have had seizures in the past, or who have conditions that increase their risk for seizures.

INVEGA and similar medications can raise the blood levels of a hormone known as prolactin, causing a condition known as hyperprolactinemia. Blood levels of prolactin remain elevated with continued use. Some side effects seen with these medications include the absence of a menstrual period; breasts producing milk; the development of breasts by males; and the inability to achieve an erection. The connection between prolactin levels and side effects is unknown.

High blood sugar and diabetes have been reported with INVEGA and similar medicat
'/>"/>

SOURCE Johnson & Johnson
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. New study shows promise in reducing surgical risks associated with surgical bleeding
2. New research shows how chronic stress worsens neurodegenerative disease course
3. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
4. Circulating fats kill transplanted pancreas cells, study shows
5. New Heart Pump Shows Promise in Trial
6. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
7. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
10. Avocados may help prevent oral cancer, OSU study shows
11. New Poll Shows Public Distrusts Flawed Healthcare Approach Favored by Governor and Speaker in AB 8
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... “ Harmony ” was featured on NewsWatch ... at the latest and coolest applications on the market for ... and technology expert, conducted the app review and shared with ... improve some aspect of their life. , A common mistake ... with difficulties in their life. However, hypnotherapy is intended for ...
(Date:6/3/2015)... June 03, 2015 On June 22, 2015, ... of genetic drug sensitivity (pharmacogenetic) testing that it has reimbursed ... as many as 19 million of the 49 million Medicare ... costly and life-threatening adverse drug events.(1) Sadly, if it became ... , Precision Medicine, the use of an individual’s genetic information ...
(Date:6/3/2015)... York, NY (PRWEB) June 03, 2015 Dr. ... New York Cardiac Diagnostic Center ( http://www.newyorkcardiac.com ) located in ... appointments on weekdays to his practice. In most cases, depending ... time of the day they call, they will be seen ... “My first priority as a cardiologist is to ensure that ...
(Date:6/3/2015)... DC (PRWEB) June 03, 2015 Alberto ... Award at DIA’s upcoming Annual Meeting. DIA’s Global Inspire ... leadership, level of excellence, and commitment to service on ... the Global Connector Award that annually recognizes one DIA ... has advanced the mission of DIA to foster innovation ...
(Date:6/3/2015)... Justina Molzon, MS Pharm, JD will be ... Annual Meeting. DIA’s Global Inspire Award program recognizes the ... and commitment to service on a global scale. ... Award that recognizes the “Member of the Year” who ... who has contributed to the advancement of DIA’s mission. ...
Breaking Medicine News(10 mins):Health News:An Application to Enjoy Hypnotherapy Sessions at Home was featured on NewsWatch Television 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 3Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 5Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 6Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 7Health News:NYC Cardiologist, Dr. Steven Reisman, Announces Same Day and Evening Appointments 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 3Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3
... groundbreaking Healthy Kids Program offers tools for family ... estimated at $14 billion annually- Employers and health ... of its kind personalized solution that provides tools ... and helps parents and kids become healthierMARIETTA, Ga., ...
... get on the map. , ... Washington, DC -- ... fundraiser challenge today to raise money to send lifesaving bed nets ... killer of refugees. Supporters are holding hundreds of fundraisers across the ...
... to Deliver eBill and Attachment Support for ... PECOS, N.M. and CONCORD, Calif., April 1 ... processing company serving the medical community, and ... integrated eBill and payment compliance services to ...
... to demonstrate HL7 interoperability for the Department of Defense,s MiCare System at ... ... 2009 -- iNTERFACEWARE is pleased to announce that its Iguana ... IHE demonstration of MiCare at the HIMSS Convention in Chicago next week. ...
... Más Pequeño del Mundo se ha introducido por MiCigarrillo™. El ... millones de fumadores en todo el mundo. , ... ... fumadores son adictos a la nicotina que se encuentra en ...
... talk about it with your doctor, but if childbirth ... pelvic organs, you need to know help is possible. ... Southeast Urogynecology at Women,s Specialty Center in Jackson, Miss. ... the entire southeast performing minimally invasive laparoscopic surgery at ...
Cached Medicine News:Health News:New Online Program Helps Parents Tackle Childhood Obesity 2Health News:New Online Program Helps Parents Tackle Childhood Obesity 3Health News:Nothing But Nets Launches World Malaria Day Fundraising Challenge 2Health News:Nothing But Nets Launches World Malaria Day Fundraising Challenge 3Health News:CLAIM.MD Adds Jopari Workers' Compensation Connectivity 2Health News:Iguana Selected for Department of Defense IHE Demonstration at HIMSS 09 2Health News:Iguana Selected for Department of Defense IHE Demonstration at HIMSS 09 3Health News:Cigarrillo Electronico "Excelente 2009" Introducido por MiCigarrillo™ 2Health News:Cigarrillo Electronico "Excelente 2009" Introducido por MiCigarrillo™ 3Health News:New Procedure To Correct Pelvic Prolapse Has Faster Recovery, Shorter Hospital Stay 2Health News:New Procedure To Correct Pelvic Prolapse Has Faster Recovery, Shorter Hospital Stay 3Health News:New Procedure To Correct Pelvic Prolapse Has Faster Recovery, Shorter Hospital Stay 4
(Date:6/3/2015)... 3, 2015  Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: ... on its expertise in opioid antagonists, announced today ... treating opioid overdose with intranasal naloxone, has commenced ... (NDA) to the United States Food and Drug ... naloxone, a drug intended to treat opioid overdose. ...
(Date:6/3/2015)... BARBARA, Calif. , June 3, 2015  The ... formal endorsement of a Midwife Kit as a standard ... Kit was developed by Direct Relief in consultation with ... of charge to midwives in developing countries. ... from complications related to their pregnancy or childbirth.  Skilled ...
(Date:6/3/2015)... , June 3, 2015 ... "Interventional Cardiology & Peripheral Vascular Devices Market (Embolic ... Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons ... MarketsandMarkets, the Interventional Cardiology and Peripheral Vascular Devices ... by 2019 with a CAGR of 7.4% from ...
Breaking Medicine Technology:Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 2Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 3A Kit for Every Midwife: International Confederation of Midwives Endorses Direct Relief-Developed Midwife Kit as Global Standard 2A Kit for Every Midwife: International Confederation of Midwives Endorses Direct Relief-Developed Midwife Kit as Global Standard 3A Kit for Every Midwife: International Confederation of Midwives Endorses Direct Relief-Developed Midwife Kit as Global Standard 4The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 2The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 3The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 4
... Used for temporary internal ... to the bladder. Supplied sterile ... one-time use. CAUTION: Periodic evaluation ... Sof-Flex stents must not remain ...
... Used for temporary internal ... to the bladder. Supplied sterile ... one-time use. CAUTION: Periodic evaluation ... Sof-Flex stents must not remain ...
... instrument introduction. The dual knobs allow ... and removed. The maximum diameter of ... introduced should be measured to ensure ... sterile in peel-open packages. Intended for ...
... to provide urethral drainage ... repair. The C-shape allows ... close during postoperative swelling ... maintaining urethral patency. Supplied ...
Medicine Products: